Aviva
CELG

Aviva’s Celgene Corp CELG Stock Holding History

Aviva’s Portfolio CELG Stock Details CELG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		– Sell
-251,294
Closed -$25M – 963
2019
Q3 		$25M Sell
251,294
-12,057
-5% -$1.15M 0.17% 122
2019
Q2 		$24.3M Sell
263,351
-126,360
-32% -$12M 0.17% 126
2019
Q1 		$36.8M Buy
389,711
+610
+0.2% +$53.3K 0.25% 95
2018
Q4 		$24.9M Sell
389,101
-79,840
-17% -$5.89M 0.19% 122
2018
Q3 		$42M Sell
468,941
-59,699
-11% -$5.28M 0.23% 106
2018
Q2 		$42M Buy
528,640
+14,035
+3% +$1.17M 0.25% 97
2018
Q1 		$45.9M Sell
514,605
-50,731
-9% -$4.87M 0.28% 95
2017
Q4 		$59M Sell
565,336
-43,337
-7% -$4.89M 0.33% 73
2017
Q3 		$88.7M Buy
608,673
+7,406
+1% +$1.01M 0.48% 46
2017
Q2 		$78.1M Buy
601,267
+3,500
+0.6% +$429K 0.44% 48
2017
Q1 		$74.4M Sell
597,767
-15,488
-3% -$1.85M 0.43% 49
2016
Q4 		$71M Buy
613,255
+31,735
+5% +$3.53M 0.42% 50
2016
Q3 		$60.8M Buy
581,520
+24,858
+4% +$2.69M 0.38% 57
2016
Q2 		$54.9M Buy
556,662
+104,125
+23% +$10.8M 0.38% 57
2016
Q1 		$45.3M Buy
452,537
+6,562
+1% +$676K 0.34% 63
2015
Q4 		$53.4M Sell
445,975
-3,702
-0.8% -$428K 0.41% 59
2015
Q3 		$48.6M Sell
449,677
-14,729
-3% -$1.83M 0.4% 60
2015
Q2 		$53.8M Buy
464,406
+15,469
+3% +$1.77M 0.38% 62
2015
Q1 		$51.8M Buy
448,937
+98,975
+28% +$11.8M 0.35% 64
2014
Q4 		$39.1M Sell
349,962
-1,110
-0.3% -$117K 0.3% 79
2014
Q3 		$33.3M Buy
351,072
+8,100
+2% +$731K 0.26% 86
2014
Q2 		$29.5M Sell
342,972
-9,110
-3% -$693K 0.23% 102
2014
Q1 		$24.6M Buy
352,082
+8,620
+3% +$683K 0.2% 122
2013
Q4 		$29M Buy
343,462
+117,772
+52% +$9.32M 0.24% 102
2013
Q3 		$17.4M Buy
225,690
+65,686
+41% +$4.6M 0.15% 171
2013
Q2 		$9.35M Buy
+160,004
New +$9.63M 0.09% 244

Other funds holding CELG

FP
Factorial Partners Mt. Kisco, New York $138M AUM 25.59% 1-Year Est. Return
HCM
Howard Capital Management Roswell, Georgia $6.11B AUM 33.56% 1-Year Est. Return
PCMC
Private Capital Management (Colorado) Denver, Colorado $501M AUM 17.09% 1-Year Est. Return
WCG
Weaver Consulting Group Huntington Beach, California $420M AUM 14.29% 1-Year Est. Return

Aviva's CELG Position: Q4 2019 in Review

Aviva sold out of Celgene Corp (CELG) in Q4 2019, closing a stake of 251,294 shares — an estimated $25M sold.

Aviva first reported a position in CELG in Q2 2013 and held it in 26 quarters. The position peaked at $88.7M in Q3 2017. 4 funds tracked by Wall St. Rank hold CELG as of Q4 2019.

  • Aviva reported no remaining Celgene Corp position as of Q4 2019 after selling out during the quarter.
  • Aviva sold 251,294 Celgene Corp shares in Q4 2019, an estimated $25M.
  • Aviva first reported a position in Celgene Corp in Q2 2013 and held it in 26 quarters.
  • Aviva's Celgene Corp position peaked at $88.7M in Q3 2017.
  • 4 funds tracked by Wall St. Rank held Celgene Corp as of Q4 2019.

Based on Aviva's 13F filing for Q4 2019, filed 10 Feb 2020.